Ideally suited for
- Doctors and medical professionals
- Companies
- Hospital staff
- Laboratories
- Doctors' practices
Roche SARS-CoV-2 & Influenza A/B Antigen Rapid Test, 25 pcs.
by Roche
Original price
€213,74
-
Original price
€213,74
Original price
€213,74
incl. VAT
€213,74
-
€213,74
Current price
€213,74
incl. VAT
Current price
€178,12
excl. VAT
€178,12
excl. VAT
- Sample collection nasopharyngeal (from the back of the nose)
- Detects influenza (influenza A & B) and the corona virus
- Tests positive also for Omicron & South African, British and Indian mutation
- Can be performed by the patient under the supervision of healthcare professionals
- Specificity SARS-COV 2: 98.59%, influenza A: 100%, influenza B: 99.04%
- Sensitivity SARS-COV 2: 84.85%, influenza A: 81.16%, influenza B: 100%
- MHD: 04/09/2024
SKU 453-5
GTIN: 8809319398301
PZN: 5633566
Manufacturer part number: 9366997023
Country of origin:
Scope of delivery
- Test strips (individually packed in a packaging bag with desiccant)
- Tubes with extraction buffer and holder for buffer tubes
- Dispenser cap
- Sterile swab
- Instructions for use and quick start guide
- Positive control swab for SARS-CoV-2
- Positive control swab for influenza A/B
- Negative control swab for SARS-CoV-2 & Influenza A/B
Product description
SARS-CoV-2 & Influenza A/B Antigen Rapid Test in detail
The SARS-CoV-2 & Flu A/B Rapid Test is a chromatographic immunoassay for the simultaneous qualitative detection and differentiation of the nucleocapsid antigens of SARS-CoV-2, influenza virus A and influenza virus B in human nasopharyngeal swab specimens. This product is intended for professional use in laboratory and near-patient testing environments.
The SARS-CoV-2 & Influenza A/B Antigen Rapid Test distinguishes between infection with SARS-CoV-2 or influenza A or B with a single sample. The test is performed in 4 steps and the test result can be read after 15 minutes. The test is fully integrated and the pack includes a positive and negative control.
The clinical performance of the SARS-CoV-2 & Flu A/B Rapid Antigen Test was evaluated in a prospective all-comers study in the USA. This study was conducted at 4 clinical centres with a near-patient testing environment. Patients over the age of 14 who presented to the testing centres for testing and had symptoms suggestive of upper respiratory tract infections such as COVID-19 or influenza were invited to participate in the study. Individuals who had more than 7 days since the onset of symptoms were excluded. 2 nasopharyngeal swabs were taken from each study participant. In a randomised manner, 1 swab was tested immediately at the study site using the SARS-CoV-2 & Flu A/B Rapid Antigen Test, while the other was sent to a central laboratory for testing using a highly sensitive, US FDA-approved multiplex RT-PCR method as a comparison method.
If you are unsure about the application, please ask your doctor or pharmacist.
This product is non-returnable.
Technical specifications
Specificity SARS-COV 2: 98.59%, Influenza, A: 100%, Influenza B: 99.04%
Sensitivity SARS-COV 2: 84.85%, Influenza, A: 81.16%, Influenza B: 100%
Advantages
- 2-in-1 test
- also suitable for non-professionals
- fast and precise results
Original price
€213,74
-
Original price
€213,74
Original price
€213,74
incl. VAT
€213,74
-
€213,74
Current price
€213,74
incl. VAT
Current price
€178,12
excl. VAT
€178,12
excl. VAT
Volume discount
| Amount | Discount | Price |
|---|---|---|
| 3+ | 3% | €207,33 |
* Maximum 5 volume discounts applicable at the same time
Free returns
Trusted Shops buyer protection
Klarna purchase on account
Free shipping from €50